Björn Degel

Michael Acceptor Based Antiplasmodial and Antitrypanosomal Cysteine Protease Inhibitors with Unusual Amino Acids

Alexander Breuning, Björn Degel, F. A. Schulz et al. · Journal of Medicinal Chemistry · 2010 · 51 citations · Full text

Bioorganic Chemistry, Antiparasitic Agent, Protease Inhibition +18

Screening of Protease Inhibitors as Antiplasmodial Agents. Part I: Aziridines and Epoxides

F. A. Schulz, Christoph Gelhaus, Björn Degel et al. · ChemMedChem · 2007 · 46 citations

Screening of electrophilic compounds yields an aziridinyl peptide as new active-site directed SARS-CoV main protease inhibitor

Erika Martina, Nikolaus Stiefl, Björn Degel et al. · Bioorganic & Medicinal Chemistry Letters · 2005 · 41 citations · Full text

Electrophilic Compounds Yields, Biochemistry, Aziridinyl Peptide +8

Tetracycline-Inducible Expression of Individual Secreted Aspartic Proteases in <i>Candida albicans</i> Allows Isoenzyme-Specific Inhibitor Screening

Peter Staib, Ulrich Lermann, Julia Blaβ-Warmuth et al. · Antimicrobial Agents and Chemotherapy · 2007 · 40 citations · Full text

<i>Cis</i>‐Configured Aziridines Are New Pseudo‐Irreversible Dual‐Mode Inhibitors of <i>Candida albicans</i> Secreted Aspartic Protease 2

Björn Degel, Peter Staib, Sebastian Rohrer et al. · ChemMedChem · 2007 · 23 citations